Merge empowers healthcare organizations with advanced medical imaging solutions to enhance workflows, optimize care delivery, and improve patient outcomes. Trusted by 6 of the 10 largest U.S. health systems, Merge’s portfolio includes: Vendor-Neutral Archive (VNA) for secure, enterprise-wide data management, PACS with multi-specialty support and advanced mammography capabilities, Workflow Orchestration to streamline radiology operations with AI-powered caseload management, Cardiology solutions for improved hemodynamics workflows and comprehensive CVIS support, Digital Pathology solutions, delivered with Indica Labs, for streamlined pathology study management, Cloud-native solutions, providing secure, scalable, and efficient deployments for seamless data migration and storage. Learn more at merative.com/merge-imaging. | MERGE, the 2025 Modern Healthcare Agency of the Year, is a marketing and technology agency that helps brands navigate complex consumer journeys through data-driven “Whole Human Marketing.” We combine deep expertise in health and consumer behavior with strategy, creativity, experience technology, and digital marketing to design personalized experiences that drive meaningful results. MERGE helps brands build trust and drive growth by treating every member and patient as an audience of one.
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. | Verona Pharma is a subsidiary of Merck& Co, Inc.,(Rahway, New Jersey, USA). For more information, please visit www.veronapharma.com. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. | We aspire to be the premier research-intensive biopharmaceutical company | We aspire to be the premier research-intensive biopharmaceutical company. Our purpose: We use the power of leading-edge science to help save and improve lives around the world For more than 130 years, and since 1911 in Canada, Merck has brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Medtronic
Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. | We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. | We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary. | We lead global healthcare technology. Our Mission: to alleviate pain, restore health, & extend life, unites a global team of people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary. | edtronic is a global leader in medical technology dedicated to improving healthcare and transforming patient outcomes through innovation and collaboration. Through its technologies, the Coronary and Renal Denervation operating unit seeks to improve health for the one billion people living with high blood pressure globally, and the 315 million people living with coronary artery disease around the world. | Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission – to alleviate pain, restore health, and extend life – unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second.
Median Technologies
Median Technologies is pioneering next-generation software as a medical device and imaging services, leveraging advanced AI to improve the precision of cancer early diagnosis and treatment. Our offerings feature iCRO, providing central imaging services and AI based image analysis for oncology trials, and eyonis®, an AI/ML-powered suite of Software as a Medical Device (SaMD). We empower biopharma companies and clinicians to accelerate the development of innovative therapies and elevate patient care. Headquartered in France with operations in the U.S. and China, Median Technologies is listed on Euronext Growth. | A pioneer in applying artificial intelligence technologies to medical imaging, Median Technologies develops and markets eyonis® — a suite of AI-powered Software as a Medical Device for the early diagnosis of solid tumor cancers. The first device of the eyonis® portfolio, eyonis® LCS, is designed for lung cancer screening procedures. eyonis® LCS is currently under review for FDA 510(k) clearance in the U.S. and CE marking in Europe. In addition to its Software as a Medical Device business, Median also provides central imaging services and AI-based image analysis for oncology clinical trials in the biopharmaceutical industry through its iCRO business.
Medallion
Medallion is the only AI-assisted credentialing and enrollment platform with expert oversight — built to deliver speed and accuracy at scale, with contract-backed performance. Healthcare organizations are empowered to manage and grow their provider networks with unparalleled speed, accuracy and elevated provider satisfaction levels with our AI-assisted model — freeing teams to focus on what matters most: delivering care. Through this, Medallion enables healthcare organizations to prioritize clinical excellence instead of admin overhead. | Medallion is the only AI-assisted credentialing and enrollment platform with expert oversight — built to deliver speed and accuracy at scale, with contract-backed performance. Healthcare organizations are empowered to manage and grow their provider networks with unparalleled speed, accuracy and elevated provider satisfaction levels with our AI-assisted model.
Manta Cares
Manta Cares is a platform to support cancer patients and care partners, from diagnosis to survivorship. We provide clinically validated information, practical tools, and a community of support to help navigate the highs and lows of the cancer experience.
Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. We harness our deep expertise in surgery, orthopedics, vision, and interventional solutions to design healthcare solutions that are smarter, less invasive, and more personalized. To learn more about how we develop med tech that helps save lives and redefine what it feels like to be a patient, visit https://thenext.jnjmedtech.com/ | The MONARCH™ Platform is transforming medical intervention and improving patient lives. At Ethicon, we seek to leverage the power of flexible robotics to diagnose lung nodules earlier. The MONARCH™ Platform integrates a variety of technologies designed to empower physicians with greater reach, uninterrupted vision, and meticulous control to help confront the challenges they face when biopsying small, peripheral lung nodules. | As Johnson & Johnson MedTech, we are an emerging leader in neurovascular care, changing the trajectory of stroke through our portfolio of products
Intuitive Surgical
At Intuitive®, innovating for minimally invasive care is the passion that drives us. Our robotic-assisted da Vinci® Surgical System helps empower doctors and hospitals to make surgery less invasive than an open approach. | At Intuitive®, innovating for minimally invasive care is the passion that drives us. The Ion endoluminal system is Intuitive’s robotic-assisted platform for minimally invasive biopsy in the lung. We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when nodules are small and located in the peripheral lung. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung.